risperidone has been researched along with Infection, Toxoplasma gondii in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibrahim, I | 1 |
| Tobar, S | 1 |
| Fathi, W | 1 |
| ElSayed, H | 1 |
| Yassein, A | 1 |
| Eissa, A | 1 |
| Elsheshtawy, E | 1 |
| Elboraei, H | 1 |
| Shahda, M | 1 |
| Elwasify, M | 1 |
| Ibrahim, A | 1 |
| Chen, K | 1 |
| Wood, J | 1 |
| Dickerson, F | 1 |
| Yolken, RH | 1 |
| El Chennawi, F | 1 |
| Gur, R | 2 |
| El Bahaey, W | 1 |
| Nimgaonkar, V | 1 |
| Mansour, H | 1 |
1 trial available for risperidone and Infection, Toxoplasma gondii
| Article | Year |
|---|---|
Randomized controlled trial of adjunctive Valproate for cognitive remediation in early course schizophrenia.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Cognitive Dysfunction; Double-Blind Metho | 2019 |